Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression

D Zhang1, S Vuocolo, V Masciullo

  • 1Department of Microbiology & Immunology, Temple University School of Medicine, 3400 North Broad Street, Philadelphia, Pennsylvania, PA 19140, USA.

Oncogene
|December 26, 2001
PubMed

Insights

All-trans-retinoic acid (RA) affects ovarian carcinoma cell growth by altering cell cycle gene expression. RA-sensitive cells show increased levels of tumor suppressors and cell cycle inhibitors, suggesting pocket protein pathways are key targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Ovarian carcinoma is a significant health concern.
  • Understanding the mechanisms of retinoid action in cancer is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the effect of all-trans-retinoic acid (RA) on cell cycle gene expression in RA-sensitive and RA-resistant ovarian carcinoma cell lines.
  • To identify key molecular targets of RA in suppressing ovarian cancer cell growth.

Main Methods:

  • Gene expression analysis using multiprobe RNAse protection assays.
  • Protein level analysis via Western blotting and in vitro kinase assays.
  • Assessment of protein-protein interactions, including p27-cyclin E and RB-2/p130-E2F4 complexes.

Main Results:

  • RA-sensitive cells (CA-OV3) exhibited higher expression of p53, p27, p21, and p16 compared to RA-resistant cells (SK-OV3).
  • RA treatment decreased hyperphosphorylated Retinoblastoma protein (RB) and RB-2/p130, while increasing hypophosphorylated forms.
  • RA treatment elevated cyclin-dependent kinase (CDK) inhibitor p27 expression and reduced CDK 2, 4, and 6 activity.

Conclusions:

  • Pocket protein pathways are critical targets for retinoid-mediated suppression of ovarian carcinoma cell growth.
  • Differential expression of cell cycle regulators and their interactions underlies retinoid sensitivity in ovarian cancer.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...